Delayed encephalopathy after acute carbon monoxide poisoning: a case study.
Přemysl VlčekIvana MonkovaZoran NerandzicMarcela Lippert-GrünerPublished in: Brain injury (2024)
Delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) is a relatively rare inflammatory-associated neurometabolic complication. In this article, we present a case report of a 50-year-old male patient with a history of carbon monoxide poisoning. This acute poisoning, although successfully controlled during a stay in the intensive care unit of a local hospital, later led to persistent neurological symptoms. The patient was then treated in the inpatient unit of the rehabilitation clinic, where cognitive deterioration began to develop 20 days after admission. Subsequent examination using EEG and magnetic resonance imaging confirmed severe encephalopathy later complicated by SARS-CoV-2 infection with fatal consequences due to bronchopneumonia. Because currently there are no approved guidelines for the management of DEACMP, we briefly discuss the existing challenges for future studies, especially the application of rational immunosuppressive therapy already in the acute treatment phase of CO poisoning, which could prevent the development of a severe form of DEACMP.
Keyphrases
- early onset
- magnetic resonance imaging
- liver failure
- drug induced
- case report
- emergency department
- mental health
- palliative care
- aortic dissection
- computed tomography
- current status
- functional connectivity
- mesenchymal stem cells
- magnetic resonance
- adverse drug
- case control
- resting state
- bone marrow
- brain injury
- respiratory syndrome coronavirus
- smoking cessation
- coronavirus disease
- acute respiratory distress syndrome
- cerebral ischemia